NSE:YESBANK.NS 5 February 2026

March 19, 2026, 9:35 AM EDT. Caleres (NYSE:CAL) exceeded Wall Street expectations in Q4 CY2025, posting revenue of $695.1 million, an 8.7% increase year-on-year and 1.4% above estimates. The company reported a non-GAAP loss per share of $0.06, outperforming analyst forecasts by 85.1%. Despite the strong quarter, Caleres' adjusted EPS guidance for 2026 at $1.50 slightly missed estimates by 0.9%. Operating margin fell to -3.8% from 2.5% last year, reflecting cost pressures, but free cash flow margin improved to 6.6%. The stock surged on results. Caleres, owner of Dr. Scholl's, has seen mixed long-term growth, with weak 5.4% compound annual sales growth over five years and revenue declines recently. Analysts expect 4.9% revenue growth next year, below sector average, amid competitive footwear market dynamics.